Biotech Co., Ltd. announced that on July 21, 2026, the company completed the cancellation of 3.3016 million repurchased shares, accounting for 0.30% of the total share capital before cancellation. The company completed the share repurchase from 2022 to 2023, partially transferred to the employee stock ownership plan in 2023, and the remaining 3.3016 million shares were cancelled. After cancellation, the total share capital of the company was reduced from 1,112 billion shares to 1,108 billion shares. This cancellation has no significant impact on the company's finances, etc., and the registration of industrial and commercial changes will be applied for in the future.

Zhitongcaijing · 2d ago
Biotech Co., Ltd. announced that on July 21, 2026, the company completed the cancellation of 3.3016 million repurchased shares, accounting for 0.30% of the total share capital before cancellation. The company completed the share repurchase from 2022 to 2023, partially transferred to the employee stock ownership plan in 2023, and the remaining 3.3016 million shares were cancelled. After cancellation, the total share capital of the company was reduced from 1,112 billion shares to 1,108 billion shares. This cancellation has no significant impact on the company's finances, etc., and the registration of industrial and commercial changes will be applied for in the future.